Guided Therapeutics (GTHP) Interest Coverage Ratio (2010 - 2026)
Guided Therapeutics (GTHP) posted Interest Coverage Ratio of 1.23 for Q4 2025, up 67.27% sequentially from 3.76 in Q3 2025, and up 69.12% YoY from 0.73 in Q4 2024.
Guided Therapeutics (GTHP) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Interest Coverage Ratio for 16 years, with the latest figure at 1.23 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 69.12% year-over-year to 1.23 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 2.35 (up 80.62% YoY) and the FY2025 annual result came in at 0.14, down 13.58% from the prior year.
- Interest Coverage Ratio rose to 1.23 in Q4 2025 per GTHP's latest filing, from 3.76 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 4.9 in Q4 2023 and troughed at 13.09 in Q2 2023.
- A 5-year average of 3.65 and a median of 2.83 in 2024 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 195.98% in 2022, down 863.18% in 2022.
- Over 5 years, Interest Coverage Ratio stood at 0.88 in 2021, then jumped by 195.98% to 2.61 in 2022, then jumped by 87.59% to 4.9 in 2023, then plunged by 181.34% to 3.99 in 2024, then jumped by 69.12% to 1.23 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 1.23, 3.76, and 4.86 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 4.82 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 11.77 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 10.64 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.27 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 6.48 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -8.96 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 18.09 |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | -3.51 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.53 |
| Dec 31, 2025 | -1.23 |
| Sep 30, 2025 | -3.76 |
| Jun 30, 2025 | -4.86 |
| Mar 31, 2025 | -2.82 |
| Dec 31, 2024 | -3.99 |
| Sep 30, 2024 | -2.85 |
| Jun 30, 2024 | -8.73 |
| Mar 31, 2024 | -5.61 |
| Dec 31, 2023 | 4.90 |
| Sep 30, 2023 | -2.00 |
| Jun 30, 2023 | -13.09 |
| Mar 31, 2023 | -12.77 |
| Dec 31, 2022 | 2.61 |
| Sep 30, 2022 | -7.90 |
| Jun 30, 2022 | -2.80 |
| Mar 31, 2022 | -4.39 |
| Dec 31, 2021 | 0.88 |
| Sep 30, 2021 | -0.82 |
| Jun 30, 2021 | -1.78 |